//News

Alzheimer’s disease virus research spotlighted at HHV-6 conference

Evidence indicating human herpesvirus 6 (HHV-6) and related herpesviruses may contribute to the causation of Alzheimer’s disease was presented in late June in a day-long session of the 11th international HHV-6 Conference, in Quebec City, reports Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc. (AGQ) who […]

2019-07-08T17:27:41+00:00 July 8, 2019|News|

New “Beehive Theory” asserts germs may cause the late damage in traumatic brain injury

Microbes may be responsible for the deterioration in brain function seen years after participation in football, boxing, soccer and other contact sports, and in soldiers who survive blast injuries, asserts Leslie Norins, M.D., Ph.D. in his new “Beehive Theory.” His formulation was recently published in the peer-reviewed medical journal, […]

2019-05-06T15:36:19+00:00 April 29, 2019|News|

New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer’s disease

New government research grant funds targeted at infectious agents will accelerate investigations into the possible roles of germs in triggering or promoting Alzheimer’s disease”, says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

The new monies were made known to scientists through a Funding Opportunity Announcement […]

2019-04-08T18:14:28+00:00 April 8, 2019|News|

NIA Advisory Council deems Alzheimer’s microbes an “Approved Concept” to receive research grant funds

At its most recent meeting the National Advisory Council on Aging (NACA), which advises NIH’s National Institute of Aging, took official note of the accumulated and expanding number of research reports that microbes may be playing an important role in the etiology of Alzheimer’s disease by elevating that topic to […]

2019-03-15T15:18:37+00:00 March 18, 2019|News|

Alzheimer’s Germ Quest has joined the ACT-AD coalition for accelerating development of Alzheimer’s disease therapies, reports Dr. Leslie Norins

Alzheimer’s Germ Quest, Inc., has become a member of the national coalition Accelerate Cure/Treatments for Alzheimer’s Disease, announces Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest.

Familiarly known as ACT-AD, the coalition is a group of more than 50 national organizations, chaired by the Alliance for Aging Research.  The coalition’s mission is making the […]

2019-02-11T16:02:53+00:00 February 11, 2019|News|